Andy and JT welcome you to another episode of The Deal Board Podcast. This week, Andy speaks with Andrew Bab of Debevoise & Plimpton about the high-stakes world of healthcare mergers and acquisitions. From billion-dollar deal structures and the teams required to execute them, to the common reasons major transactions fall apart, Andy and Andrew unpack the complexity behind large-scale deals. They also explore how private equity’s “dry powder” — the trillions of dollars firms keep in reserve to deploy into future deals — and the rise of AI-driven healthcare solutions are shaping the future of the industry. Tune in for an insider’s view of what it takes to get big deals across the finish line and where opportunities are emerging in healthcare M&A! 

Listing of the Week: 

Rally de Leon, broker with Transworld Business Advisors of Raleigh, presents a premier cabinet refinishing franchise in a prime market. The down payment is priced at $149,900, and the business generates nearly $500,000 in sales with $85,000 in SDE last year. Because the current owners live two hours away, growth has been limited, but with local leadership, revenue could easily double. For more information, call Rally at (919) 602-0355 or email rdeleon@tworld.com

Deal of the Week:

Alexander Woo, broker with Transworld Business Advisors of Orange County, closed his first transaction: a long-standing hair salon. Though the business wasn’t profitable, the seller needed a quick exit before relocating abroad. By repositioning it as a cost-effective alternative to starting a new salon, Alex secured a buyer within three months and closed escrow in two more. The buyer gained a ready-to-operate salon at a fraction of startup costs, while the seller moved stress-free. For more information, call Alexander at (714) 923-1222 or email awoo@tworld.com 

Key Takeaways From This Episode:  

• [00:30 ] An overview of today’s topic: Large M&A deals. 

• [03:00 ] Introducing Andrew Bab and his path from investment banking to law and healthcare M&A. 

• [07:04 ] The current state of healthcare and M&A amid market uncertainty, regulation, and healthcare antitrust hurdles. 

• <span class="NormalTex